Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 11,929 | 13,154 | 14,499 | 20,300 | 21,088 |
| Operating Income | -11,929 | -13,154 | -14,499 | -20,300 | -21,088 |
| Interest Expense | 2,699 | 2,303 | 2,312 | 2,327 | 1,302 |
| Other Income | 70 | 14 | 4 | 1 | 4 |
| Pre-tax Income | -14,558 | -15,443 | -16,807 | -22,626 | -22,386 |
| Net Income Continuous | -14,558 | -15,443 | -16,807 | -22,626 | -22,386 |
| Net Income | $-14,558 | $-15,443 | $-16,807 | $-22,626 | $-22,386 |
| EPS Basic Total Ops | -0.54 | -0.58 | -0.63 | -0.86 | -0.88 |
| EPS Basic Continuous Ops | -0.54 | -0.58 | -0.63 | -0.86 | -0.88 |
| EPS Diluted Total Ops | -0.54 | -0.58 | -0.63 | -0.86 | -0.88 |
| EPS Diluted Continuous Ops | -0.54 | -0.58 | -0.63 | -0.86 | -0.88 |
| EBITDA(a) | $-11,899 | $-13,123 | $-14,035 | $-20,194 | $-20,986 |